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Introduction
Phosphate is an electrolyte playing a role in the regulation of 
calcium levels, arrangement of carbohydrate and lipid metabolism, and 
maintaining acid-base balance. Hypophosphatemia may develop as a 
result of renal loss, chronic alcoholism, diabetes, burns, gastrointestinal 
loss, diuretics, and antiacids. Muscle weakness, paresthesia, confusion, 
Öz
Fosfor hücreler için yapısal bir molekül olup ayrıca koenzim ya da ikincil haberci 
olarak kullanılmaktadır. Fosfatın renal ve gastrointestinal kayıpları, diyabetis mellitus, 
hiperparatiroidizm, kronik alkolizm, sepsis, glukokortikoid fazlalığı, diüretikler ve 
antiasitler hipofosfatemiye neden olabilir. Kas güçsüzlüğü, parestezi, konfüzyon, 
nöbet, tremor ve koma hipofosfateminin nörolojik bulgularındandır. Temel klinik 
bulgular dokulara oksijen dağılımındaki bozulmaya ve hücre içi adenozin trifosfatın 
azalmasına bağlı olarak gelişir. Hipofosfateminin tedavisinde altta yatan nedenin 
belirlenmesi önemlidir. Bu yazıda D vitamini eksikliğine bağlı hipofosfateminin 
neden olduğu parestezili 26 yaşındaki genç erkek hasta sunulmuştur. Klinisyenler 
parezi ve/veya parestezili hastaları incelerken diğer elektrolitlere göre daha nadir 
görülen fosfor bozuklukları hakkında dikkatli olmalıdır.
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Phosphate is a structural molecule for cells and also is used as coenzyme or as seconder 
messenger. Renal or gastrointestinal loss of phosphate, diabetes mellitus, chronic 
alcoholism, hyperparathyroidism, sepsis, increased glucocorticoid, diuretics and 
antacids may cause hypophosphatemia. Muscle weakness, paresthesia, confusion, 
convulsion, tremor and coma are neurological symptoms of hypophosphatemia. 
Main clinical signs occur due to deterioration oxygen distribution and reduced 
intracellular adenosine triphosphate. In the treatment of hypophosphatemia 
identification of underlying causes is important. In this article, a 26-year-old 
young male patient with paresthesia that is caused by hypophosphatemia due to 
D vitamin deficiency is reported. Clinicians must be on the alert about phosphate 
imbalance which is seen more rare than other electrolytes when investigation of 
patients with paresis and/or paresthesia.
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seizure, tremor, and coma are neurological symptoms 
of hypophosphatemia. Identification of the underlying 
cause is an important step for determining the etiology 
of hypophosphatemia. The treatment includes oral 
or intravenous replacement of phosphate. In this 
paper a 26-year-old male patient who was admitted 
to emergency with paresthesia due to vitamin D 
deficiency induced hypophosphatemia.
Case Report
A 26-year-old man who presented with numbness 
in all four extremities was evaluated. The symptoms 
began at the distal of extremities and added upwards 
and with increasing intensity in the last 2 weeks. He 
additionally had myalgia. He had no history of smoking 
or alcohol use, nor he had any systemic disease. He also 
had no familial history of any disease. On neurological 
examination he was conscious, and had orientation, 
cooperation. His pupils were isocoric; his light reflexes 
were bilaterally normal; his eye movements were 
unrestricted in every direction; he had no nystagmus 
or facial asymmetry; and he had intact lower cranial 
nerves and motor function. However, he had diffuse 
patchy paresthesia on sensory testing; his deep tendon 
reflexes were hypoactive; and his plantar responses 
were bilaterally flexor. In laboratory tests, serum 
glucose, hemoglobin, biochemical parameters (urea, 
creatinine, sodium, potassium, calcium, chloride, 
magnesium, ALT, AST and thyroid function tests, and 
vitamin B12 and folic acid levels) were within normal 
ranges.
The phosphate level was 1.3 mg/dL (normal 
range 2.5-4.5 mg/dL). A search for the cause of 
hypophosphatemia found normal parathormone 
and glucocorticoid hormone levels and a low vitamin 
D level (5.7 ng/dL; normal range 20-120 ng/dL). 
Vitamin D deficiency induced hypophosphatemia was 
considered as the primary diagnosis. The patient’s 
neurological examination completely returned to 
normal within 72 hours of phosphate replacement. A 
search for the cause of vitamin D deficiency revealed no 
signs of symptoms of nutritional deficiency, intestinal 
malabsorbtion (celiac disease, crohn disease, cystic 
fibrosis, gastric or intestinal perforation), hepatic or 
renal disorders, abnormal hepatic or renal function 
tests, or any malaborbtion syndrome affecting vitamin 
B12 or folic acid levels. He also lacked any history of the 
use of medications preventing vitamin D absorbtion, 
including corticosteroids, orlistat, cholestiramine, 
or phenytoin. There was also no history of sunlight 
avoidance causing deficient sunlight exposure. The 
patients was also administered treatment against 
vitamin D deficiency.
Discussion
Phosphate is a structural molecule for human 
cells which is also used as a coenzyme or second 
messenger. Human body normally contains 600-700 
mg phosphate, and approximately 1000 mg phosphate 
is consumed daily. Absorbtion of phosphate is 
the function of proximal tubule of the intestines. 
Phosphate is predominantly excreted in urine but 
some amount also in stool. Phosphate balance is 
regulated by vitamin D, parathormone, acid-base 
balance, and glucocorticoids (1). Healthy individuals 
have a phosphate level of 2.5-4.5 mg/dL.
The main mechanisms leading to 
hypophosphatemia (serum phosphate level <2.5 mg/
dL) include phosphate shift from the extracellular 
compartment to the intracellular compartment, 
reduced phosphate intake, reduced phosphate 
absorbtion from the intestines, and increased urinary 
phosphate excretion (2). Hypophosphatemia may 
develop with glucose, fructose, and aminoacid infusion 
or intravenous hyperalimentation. Hypophosphatemia 
is seen a rate of 1-5% in hospitalization. Sepsis, diabetic 
ketoacidosis, liver failure, and post-renal transplant 
period are particularly risk for hypophosphatemia, 
and patients with these conditions should be more 
closely monitored. Our patient was, however, a young 
adult without any systemic disorder or a marked risk 
factor for hypophosphatemia.
Renal losses are among the most common 
causes of hypophosphatemia. Chronic alcoholism, 
malabsorbtion, burns, hypothermia, diabetes, renal 
losses, vitamin D deficiency, prolonged vomiting, 
glucocorticoid excess, hyperparathyroidism, antiacid, 
thiazide diuretic, and phosphate binding agent use 
are some major causes of hypophophatemia.
Hypophosphatemia is rarely symptomatic unless 
serum phosphate level is reduced below 2 mg/
dL. Affected patients are typically asymptomatic, 
with signs and symptoms occurring with deep 
hypophosphatemia. Main clinical signs and symptoms 
emerge as a result of disturbed tissue oxygenization 
and reduced intracellular adenosine triphosphate 
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concentration (3-5). The patient’s phosphate was 1.3 
mg/dL which caused the symptoms. 
The signs and symptoms may involve all organs and 
systems. The gastrointestinal effects (loss of appetite, 
nausea, vomiting, gastric atony), neurological 
symptoms (weakness, paresthesia, ataxia, tremor, 
seizure, coma), musculoskeletal signs and symptoms 
(myalgia, fractures, bone aches, osteomalasia), 
cardiac signs and symptoms (reduced myocardial 
contractility), and hematological disturbances 
(hemolytic anemia, thrombocyte dysfunction) may all 
be found. Mohseni et al. (6) defined acute hemiparesis 
in a patient with hypophosphatmeia. The patient’s 
phosphate level was 1.3 mg/dL and displayed the 
symptoms of numbness, myalgia, and sign of diffuse 
paresthesia, and symmetrically reduced deep tendon 
reflexes. No sign related to other systems was noted. 
A complete evaluation of phosphate level requires 
the measurement of parathormone, vitamin D, and 
glucocorticoid hormone levels. In cases with reduced 
phosphate intake vitamin D deficiency may cause 
hypophosphatemia by reducing gastrointestinal 
absorbtion. Our patient had normal parathormone 
and glucocorticoid hormone levels but reduced 
vitamin D level. 
We considered that hypophosphatemia was caused 
by vitamin D deficiency. Appropriate phosphate 
replacement corrected phosphate level, and the 
correction of the underlying vitamin D deficiency 
prevented further renal phosphate loss. 
Hypophosphatemia treatment should both aim 
at phosphate replacement and the identification 
of the underlying cause (7). We also started 
vitamin D along with phosphate replacement. 
In this paper we discussed the clinical and 
laboratory features of a young male patient with 
hypophosphatemia who presented to our clinic 
with diffuse paresthesia, dissussion with literature. 
We aimed to emphasize that calling to mind phosphate 
imbalance as a rare cause of paresia and paresthesia 
along with more common electrolyte disorders such 
as sodium, potassium, calcium, and magnesium 
deficiency.
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